Significance of Randomized double-blind placebo-controlled trial
A randomized double-blind placebo-controlled trial is a clinical study design that effectively eliminates bias by ensuring that neither the participants nor the researchers know who is receiving the treatment or a placebo. This design is crucial for testing the efficacy of treatments, such as omega 3 supplementation or pyridostigmine, by randomly assigning participants to either group. The approach enhances the integrity of the results, contributing to more accurate evaluations of treatment effects in clinical research.
Synonyms: Clinical trial, Controlled study, Randomized trial, Double-blind trial, Placebo-controlled study, Rct, Randomized clinical trial, Randomized controlled trial, Placebo trial, Intervention study
The below excerpts are indicatory and do represent direct quotations or translations. It is your responsibility to fact check each reference.
The concept of Randomized double-blind placebo-controlled trial in scientific sources
The keyphrase "Randomized double-blind placebo-controlled trial" refers to a study design where participants are randomly assigned to treatment or placebo groups, ensuring unbiased results and eliminating bias through participant and researcher blinding.
From: International Journal of Pharmacology
(1) A randomized double-blind placebo-controlled trial is a study design used to evaluate the antishivering effect of low-dose meperidine in caesarean section under spinal anesthesia.[1]
From: International Journal of Environmental Research and Public Health (MDPI)
(1) Randomized double blind placebo controlled trial is mentioned as a study design used to assess NAC treatment for nail biting, with significant differences in nail length reported after one month.[2] (2) Randomized double-blind placebo controlled trial is a rigorous study design used to assess the effectiveness of vitamin D supplementation, ensuring unbiased results by comparing it against a placebo group.[3]
From: The Malaysian Journal of Medical Sciences
(1) A rigorous study design used to evaluate the efficacy and safety of a treatment, minimizing bias through randomization and blinding.[4]